NADPH oxidase is also required in humans to prevent staphylococcal skin infection, since patients with chronic granulomatous disease (CGD) that have mutations in the NADPH oxidase NOX2 subunit show enhanced susceptibility to S. aureus skin infections [74]. The gene discussed is FMO5; the disease is skin infection.